Clinical lipidology : a companion to Braunwald's heart disease
3rd edition
2023
1 ressource en ligne (390 pages)
Format PDF
Cardiovascular Disease Extended
9780323882873
Anglais
1. Overview of Lipids and Atherosclerosis -- 2. Overview of Risk Assessment -- 3. Measurement of Low-Density Lipoprotein Cholesterol, Non–High-Density Lipoprotein Cholesterol, Apolipoprotein B, and Low-Density Lipoprotein Particle Concentration -- 4. Triglycerides, Triglyceride-Rich Lipoproteins, and High-Density Lipoprotein in Coronary Heart Disease Risk Assessment -- 5. Lipoprotein(a) in Cardiovascular Risk Assessment -- 6. Clinical Evaluation for Genetic Testing and Secondary Causes of Dyslipidemia -- 7. Polygenic Risk Scores -- 8. High-Sensitivity C-Reactive Protein -- 9. Emerging Assays for Risk Assessment -- 10. Imaging Atherosclerosis for Risk Stratification: Cardiac Computed Tomography and Carotid Ultrasound -- 11. Overview of General Approach to Management of Dyslipidemias -- 12. Treatment Guidelines Overview: American Heart Association/American College of Cardiology/Multisociety Guideline and Updates -- 13. Treatment Guidelines Overview: European Society of Cardiology/European Atherosclerosis Society Guidelines -- 14. Dietary Patterns for the Prevention and Treatment of Cardiovascular Disease -- 15. Updated Clinical Guide to Exercise and Lipids -- 16. Obesity, Lipids, and Cardiovascular Disease -- 17. Statins -- 18. Cholesterol Absorption Inhibitors -- 19. Omega-3 Fatty Acids -- 20. Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition -- 21. Inclisiran -- 22. Bempedoic Acid -- 23. Pemafibrate: A New Selective Peroxisome Proliferator–Activated Receptor–α Modulator for Hypertriglyceridemia Management -- 24. Anti-inflammatory Therapy for Cardiovascular Disease -- 25. Nutraceuticals and Functional Foods for Cholesterol Reduction -- 26. Evolving Therapeutic Targets: Lipoprotein(a) -- 27. Inhibition of ANGPTL3 as a Target for Treating Dyslipidemias -- 28. Evolving Therapeutic Targets: Apolipoprotein C-III -- 29. Evolving Therapeutic Targets: Cholesteryl Ester Transfer Protein Inhibition
Part of the renowned Braunwald family of references, Clinical Lipidology: A Companion to Braunwald's Heart Disease provides today's clinicians with clear, authoritative guidance on the therapeutic management of patients with high cholesterol levels and other atherogenic lipid disorders. An invaluable resource for cardiologists, lipidologists, endocrinologists, and internal medicine physicians, this one-stop reference covers everything from basic science and the pathogenesis of atherothrombotic disease to risk assessment and the latest therapy options. Now fully updated from cover to cover, the 3rd Edition offers unparalleled coverage of lipidology in an accessible and user-friendly manner.
Appareil cardiovasculaire - Maladies / Lipides - Troubles du métabolisme / Lipoprotéines - Métabolisme